|
01/10/2020 |
OLIVO Study |
CIGB |
Registered |
|
26/11/2020 |
ABDALA Clinical Study |
CIGB |
Registered outdated |
|
26/11/2020 |
MAMBISA Study |
CIGB |
Registered outdated |
|
11/03/2021 |
CIGB2020- ARI elderly contacts |
CIGB |
Registered outdated |
|
18/03/2021 |
ABDALA Clinical Study - Phase III |
CIGB |
Registered |
|
27/03/2021 |
ABDALA-Intervention |
CIGB |
Registered |
|
09/07/2021 |
CIGB-Mambisa/Abdala in convalescents |
CIGB |
Registered outdated |
|
01/07/2021 |
Evaluation of the safety and immunogenicity of the vaccine candidate "ABDALA" in children and adolescents |
CIGB |
Registered |
|
03/09/2021 |
MEÑIQUE Study |
CIGB |
Registered |
|
20/04/2022 |
Jusvinza in rheumatoid arthritis |
CIGB |
Registered |
|
06/12/2022 |
Nasal recombinant human interferon alfa-2b in ARI |
CIGB |
Registered |
|
29/07/2022 |
Nasalferon in ARI |
CIGB |
Registered |
|
06/07/2023 |
Exploratory study to evaluate the effect and safety of CIGB 500 in seriously ill patients with shock |
CIGB |
Registered |
|
24/04/2023 |
Efficacy and safety of Jusvinza treatment in patients with acute respiratory distress syndrome. Phase II/III |
CIGB |
Registered |
|
06/09/2024 |
Evaluation of the effect and safety of a booster dose of Abdala against COVID-19. |
CIGB |
Registered |
|
13/02/2025 |
Nasalferon in respiratory infections in adults. Phase 3 clinical trial. |
CIGB |
Registered |
|
19/11/2025 |
Safety and therapeutic effect of administration of Jusvinza in the post-acute stage of Chikungunya infection |
CIGB |
Registered |
|
17/11/2025 |
Safety and therapeutic effect of administration of Jusvinza in the chronic stage of Chikungunya infection |
CIGB |
Registered |
|
28/03/2026 |
Growth hormone-releasing peptide in sepsis-induced myocardial dysfunction. |
CIGB |
Registered |
|
31/03/2026 |
Effectiveness and Safety of Jusvinza in Patients with Chikungunya |
CIGB |
Registered |
